Overview

Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?

Status:
Withdrawn
Trial end date:
2016-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Emory University
Criteria
Inclusion Criteria:

- Diagnosis of unilateral Meniere Disease (MD) per the Committee on Hearing and
Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)

- Glomerular filtration rate (GFR) > 90 mls/min/1.73 m2

- Creatinine (Cr) level serum < 1.6 mg/dl

Exclusion Criteria:

- Age < 18 years

- Diagnosis of bilateral MD

- History of prior temporal bone surgery

- History of cochlear implant placement

- Pacemaker, cardiac implantable electronic device, shrapnel, aneurysm clips or other
metal objects that are prohibited in the MR suite

- GFR < 90 mls/min/1.73m2

- Cr level > 1.6 mg/d

- Lack of IV access

- Contrast allergy to gadolinium agent

- Pregnancy

- Claustrophobia necessitating parenteral anxiolytics

- Patients who are unable to provide informed consent for themselves